Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569543 · ClinicalTrials.gov registry record
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
A clinical trial of Breast Cancer, sponsored by University of Nebraska.
- Completed
- Registry status
- 27
- Enrollment target
- 2
- Study locations
NCT00569543 is a study of Breast Cancer that has completed, run by University of Nebraska. The registered enrollment target is 27 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00569543, a study of Breast Cancer, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Studying samples of urine in the laboratory from women with breast cancer may help doctors learn whether tamoxifen and aromatase inhibitors alter the metabolism of estrogens. PURPOSE: This clinical trial is studying the effect of tamoxifen or an aromatase inhibitor on estrogen metabolism in women undergoing treatment for newly diagnosed breast cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER high performance liquid chromatography
- OTHER mass spectrometry
Study Locations (2)
Minnesota
- Mayo Clinic Cancer Center - Rochester
Nebraska
- Eppley Cancer Center at University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2005-05-11 |
| Est. Completion | 2012-08-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00569543
The ClinicalTrials.gov registry entry for NCT00569543 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00569543 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Nebraska.
Frequently Asked Questions
What is clinical trial NCT00569543 about?
NCT00569543 is a clinical study titled "Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer". RATIONALE: Studying samples of urine in the laboratory from women with breast cancer may help doctors learn whether tamoxifen and aromatase inhibitors alter the metabolism of estrogens. PURPOSE: This clinical trial is studying the effect of tamoxifen or an aromatase inhibitor on estrogen metabolism...
What is the current status of trial NCT00569543?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2005-05-11. Estimated completion is 2012-08-02.
What conditions does trial NCT00569543 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00569543?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), high performance liquid chromatography (OTHER), mass spectrometry (OTHER).
Who is sponsoring clinical trial NCT00569543?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00569543 being conducted?
This trial has 2 study locations across Minnesota, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.